Literature DB >> 23351823

Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study.

Luna Gargani1, Alberto Pignone, Gergely Agoston, Antonella Moreo, Eugenia Capati, Luigi P Badano, Marica Doveri, Laura Bazzichi, Marco Fabio Costantino, Andrea Pavellini, Francesco Pieri, Francesco Musca, Denisa Muraru, Oscar Epis, Eleonora Bruschi, Benedetta De Chiara, Federico Perfetto, Fabio Mori, Oberdan Parodi, Rosa Sicari, Stefano Bombardieri, Albert Varga, Marco Matucci Cerinic, Eduardo Bossone, Eugenio Picano.   

Abstract

BACKGROUND: Patients with systemic sclerosis (SSc) are at risk for developing pulmonary hypertension, which is associated with a poor prognosis. Exercise Doppler echocardiography enables the identification of exercise-induced increase in pulmonary artery systolic pressure (PASP) and may provide a thorough noninvasive hemodynamic evaluation. AIM: The aim of this study was to evaluate the clinical and echocardiographic determinants of exercise-induced increase in PASP in a large population of patients with SSc.
METHODS: We selected 164 patients with SSc (age 58 ± 13 years, 91% female) with normal resting PASP (<40 mm Hg) who underwent a comprehensive 2-dimensional and Doppler echocardiography and graded bicycle semisupine exercise Doppler echocardiography. Pulmonary artery systolic pressure, cardiac output, and pulmonary vascular resistance (PVR) were estimated noninvasively. Cutoff values of PASP ≥50 mm Hg and PVR ≥3.0 Wood Units at peak exercise were considered a significant exercise-induced increase in PASP and PVR, respectively.
RESULTS: Sixty-nine (42%) patients showed a significant exercise-induced increase in PASP. Among them, peak PVR ≥3 Wood Units was present only in 11% of patients, about 5% of the total population. Univariate analysis showed that age, presence of interstitial lung disease, and both right and left diastolic dysfunction are predictors of peak PASP ≥50 mm Hg, but none of these parameters predict elevated peak PVR.
CONCLUSIONS: Exercise-induced increase in PASP occurs in almost one-half of patients with SSc with normal resting PASP. Peak exercise PASP is affected by age, interstitial lung disease, and right and left ventricular diastolic dysfunction and, only in 5% of the patients, is associated with an increase in PVR during exercise, suggesting heterogeneity of the mechanisms underlying exercise-induced pulmonary hypertension in SSc.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23351823     DOI: 10.1016/j.ahj.2012.10.020

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  Rest and exercise echocardiography for early detection of pulmonary hypertension.

Authors:  Kenya Kusunose; Hirotsugu Yamada
Journal:  J Echocardiogr       Date:  2015-11-30

2.  Focus on echocardiographic right ventricular strain analysis in cystic fibrosis adults without cardiovascular risk factors: a case-control study.

Authors:  Edoardo Sciatti; Enrico Vizzardi; Ivano Bonadei; Francesca Valentini; Elisa Menotti; Francesco Prati; Lucia Dallapellegrina; Marialma Berlendis; Piercarlo Poli; Rita Padoan; Marco Metra
Journal:  Intern Emerg Med       Date:  2019-05-14       Impact factor: 3.397

3.  Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance.

Authors:  Christian Cadeddu; Martino Deidda; Giuseppina Giau; Marzia Lilliu; Fabio Cadeddu; Giulio Binaghi; Mario Nicola Mura; Michela Farci; Stefano Del Giacco; Paolo Emilio Manconi; Giuseppe Mercuro
Journal:  Int J Cardiovasc Imaging       Date:  2014-12-30       Impact factor: 2.357

Review 4.  A review of exercise pulmonary hypertension in systemic sclerosis.

Authors:  Faisal Shaikh; Zafia Anklesaria; Tasneam Shagroni; Rajeev Saggar; Luna Gargani; Eduardo Bossone; Michael Ryan; Richard Channick; Rajan Saggar
Journal:  J Scleroderma Relat Disord       Date:  2019-06-14

Review 5.  Potential role of exercise echocardiography and right heart catheterization in the detection of early pulmonary vascular disease in patients with systemic sclerosis.

Authors:  Gabor Kovacs; Horst Olschewski
Journal:  J Scleroderma Relat Disord       Date:  2019-05-24

Review 6.  Update on assessment and management of primary cardiac involvement in systemic sclerosis.

Authors:  Vasiliki-Kalliopi Bournia; Christos Tountas; Athanase D Protogerou; Stylianos Panopoulos; Sophie Mavrogeni; Petros P Sfikakis
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

7.  Right ventricular thickness as predictor of global myocardial performance in systemic sclerosis: A Doppler tissue imaging study.

Authors:  S K Karna; M K Rohit; A Wanchu
Journal:  Indian Heart J       Date:  2015 Nov-Dec

8.  Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Christian Nagel; Philipp Henn; Nicola Ehlken; Antonello D'Andrea; Norbert Blank; Eduardo Bossone; Anke Böttger; Christoph Fiehn; Christine Fischer; Hanns-Martin Lorenz; Frank Stöckl; Ekkehard Grünig; Benjamin Egenlauf
Journal:  Arthritis Res Ther       Date:  2015-06-19       Impact factor: 5.156

9.  Exaggerated increase of exercise-induced pulmonary artery pressure in systemic sclerosis patients predominantly results from left ventricular diastolic dysfunction.

Authors:  Michał Ciurzyński; Piotr Bienias; Katarzyna Irzyk; Maciej Kostrubiec; Zbigniew Bartoszewicz; Maria Siwicka; Marcin Kurzyna; Urszula Demkow; Piotr Pruszczyk
Journal:  Clin Res Cardiol       Date:  2013-07-04       Impact factor: 5.460

Review 10.  Exercise echocardiography for the assessment of pulmonary hypertension in systemic sclerosis: a systematic review.

Authors:  Rui Baptista; Sara Serra; Rui Martins; Rogério Teixeira; Graça Castro; Maria João Salvador; José António Pereira da Silva; Lèlita Santos; Pedro Monteiro; Mariano Pêgo
Journal:  Arthritis Res Ther       Date:  2016-07-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.